An animal model of fibrinolytic bleeding based on the rebleed phenomenon: Application to a study of vulnerability of hemostatic plugs of different age
- 1 July 1992
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 67 (1) , 31-40
- https://doi.org/10.1016/0049-3848(92)90255-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: Potentiation by aspirin and reversal with aprotininJournal of the American College of Cardiology, 1991
- Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin.Circulation, 1990
- Aprotinin: An antidote for recombinant tissue-type plasminogen activator (rt-PA) active in vivoJournal of the American College of Cardiology, 1990
- Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.Journal of Clinical Investigation, 1989
- Tissue plasminogen activator promotes platelet disaggregation in plasma.Journal of Clinical Investigation, 1987
- Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (cy 216) in rabbitsThrombosis Research, 1986
- The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: Influence of dosage regimens in rabritsThrombosis Research, 1985
- A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.Circulation, 1985
- Effect on haemostasis of intravenous injection of α2-antiplasmin in cats treated with streptokinaseThrombosis Research, 1983
- The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory MonitoringAnnals of Internal Medicine, 1979